Curing Versus Managing CLL
Adrian Wiestner, MD, PhD, senior investigator, National Institutes of Health, discusses curing or managing patients with chronic lymphocytic leukemia (CLL).
Clinical Pearls
Adrian Wiestner, MD, PhD, senior investigator, National Institutes of Health, discusses curing or managing patients with chronic lymphocytic leukemia (CLL).
- The question remains as to whether CLL can be cured or if it should be managed over the long term.
- This answer depends on the age and comorbidities of the patient.
- The safety of CLL drugs over the course of many years in unknown.
<<<
Resistance Mutations Develop Differently After Noncovalent BTK Therapy in CLL
May 14th 2025During a live event, Shuo Ma, MD, PhD, discussed the resistance mutation analysis of patients who had disease progression after receiving pirtobrutinib for BTK inhibitor–pretreated chronic lymphocytic leukemia.
Read More
Prior Pelvic Radiation Linked to Higher Complications After Bladder Cancer Surgery
April 30th 2025Bladder cancer patients undergoing radical cystectomy after pelvic radiotherapy showed increased risks of rectal injury, readmission, sepsis, and surgical-site infections compared with primary surgery.
Read More
